Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens.

Veal GJ, Errington J, Sastry J, Chisholm J, Brock P, Morgenstern D, Pritchard-Jones K, Chowdhury T.

Cancer Chemother Pharmacol. 2016 Apr;77(4):685-92. doi: 10.1007/s00280-016-2975-0. Epub 2016 Feb 13.

2.

Hepatoprotective potential of kumaryasava and its concentrate against CCl4-induced hepatic toxicity in Wistar rats.

Khan MA, Gupta A, Sastry JL, Ahmad S.

J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):297-9. doi: 10.4103/0975-7406.168029.

3.

Hepatoprotective activity of a new polyherbal formulation against paracetamol and D-galactosamine induced hepatic toxicity.

Khan MA, Gupta A, Kumar S, Ahmad S, Sastry JL.

J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):246-9. doi: 10.4103/0975-7406.168018.

4.

Evaluation of Ratnaprash for its effect on strength, stamina and fatigue using swim endurance test and biochemical estimation in swiss albino mice.

Gupta A, Kumar S, Rajput R, Srivastava R, Rai RK, Sastry JL.

Anc Sci Life. 2015 Jul-Sep;35(1):26-31. doi: 10.4103/0257-7941.165626.

5.

Predicting, Monitoring, and Managing Hypercalcemia Secondary to 13-Cis-Retinoic Acid Therapy in Children With High-risk Neuroblastoma.

Chen SC, Murphy D, Sastry J, Shaikh MG.

J Pediatr Hematol Oncol. 2015 Aug;37(6):477-81. doi: 10.1097/MPH.0000000000000362.

PMID:
26056798
6.

Evaluation of immunostimulatory activity of Chyawanprash using in vitro assays.

Madaan A, Kanjilal S, Gupta A, Sastry JL, Verma R, Singh AT, Jaggi M.

Indian J Exp Biol. 2015 Mar;53(3):158-63.

PMID:
25872246
7.

Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV.

Mave V, Kadam D, Kinikar A, Gupte N, Bhattacharya D, Bharadwaj R, McIntire K, Kulkarni V, Balasubramanian U, Suryavanshi N, Thio C, Deshpande P, Sastry J, Bollinger R, Gupta A, Bhosale R; SWEN India and Byramjee-Jeejeebhoy Medical College Clinical Trials Unit Study team.

HIV Med. 2014 Jul;15(6):347-54. doi: 10.1111/hiv.12120. Epub 2014 Jan 14.

8.

Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India.

Ram M, Gupte N, Nayak U, Kinikar AA, Khandave M, Shankar AV, Sastry J, Bollinger RC, Gupta A; SWEN India and BJMC-JHU Clinical Trials Study Team.

BMC Infect Dis. 2012 Oct 31;12:282. doi: 10.1186/1471-2334-12-282.

9.

Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis.

Gupta A, Chandrasekhar A, Gupte N, Patil S, Bhosale R, Sambarey P, Ghorpade S, Nayak U, Garda L, Sastry J, Bharadwaj R, Bollinger RC; Byramjee Jeejeebhoy Medical College–Johns Hopkins University Study Group.

Clin Infect Dis. 2011 Nov;53(10):1015-8. doi: 10.1093/cid/cir605. Epub 2011 Sep 21.

10.

Intranasal but not intravenous delivery of the adjuvant α-galactosylceramide permits repeated stimulation of natural killer T cells in the lung.

Courtney AN, Thapa P, Singh S, Wishahy AM, Zhou D, Sastry J.

Eur J Immunol. 2011 Nov;41(11):3312-22. doi: 10.1002/eji.201041359. Epub 2011 Sep 19.

11.

High rates of all-cause and gastroenteritis-related hospitalization morbidity and mortality among HIV-exposed Indian infants.

Singh HK, Gupte N, Kinikar A, Bharadwaj R, Sastry J, Suryavanshi N, Nayak U, Tripathy S, Paranjape R, Jamkar A, Bollinger RC, Gupta A; SWEN India Study Team.

BMC Infect Dis. 2011 Jul 15;11:193. doi: 10.1186/1471-2334-11-193.

12.

Impact of maternal human immunodeficiency virus infection on pregnancy and birth outcomes in Pune, India.

Patil S, Bhosale R, Sambarey P, Gupte N, Suryavanshi N, Sastry J, Bollinger RC, Gupta A, Shankar A.

AIDS Care. 2011 Dec;23(12):1562-9. doi: 10.1080/09540121.2011.579948. Epub 2011 Jun 28.

PMID:
21711178
13.

Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.

Omer SB; Six Week Extended Dose Nevirapine (SWEN) Study Team.

AIDS. 2011 Mar 27;25(6):767-76. doi: 10.1097/QAD.0b013e328344c12a. Erratum in: AIDS. 2012 Nov 28;26(18):2427-8.

PMID:
21330912
14.

Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus.

Gupta A, Bhosale R, Kinikar A, Gupte N, Bharadwaj R, Kagal A, Joshi S, Khandekar M, Karmarkar A, Kulkarni V, Sastry J, Mave V, Suryavanshi N, Thakar M, Kulkarni S, Tripathy S, Sambarey P, Patil S, Paranjape R, Bollinger RC, Jamkar A; Six Week Extended-Dose Nevirapine (SWEN) India Study Team.

J Infect Dis. 2011 Feb 1;203(3):358-63. doi: 10.1093/infdis/jiq064.

15.

Prime-boost vaccination using chemokine-fused gp120 DNA and HIV envelope peptides activates both immediate and long-term memory cellular responses in rhesus macaques.

Qin H, Nehete PN, He H, Nehete B, Buchl S, Cha SC, Sastry JK, Kwak LW.

J Biomed Biotechnol. 2010;2010:860160. doi: 10.1155/2010/860160. Epub 2010 May 5.

16.

Primary intracranial leiomyosarcoma: a case report and review of the literature.

Mathieson CS, St George EJ, Stewart W, Sastry J, Jamal S.

Childs Nerv Syst. 2009 Aug;25(8):1013-7. doi: 10.1007/s00381-009-0845-3. Epub 2009 Mar 24. Review.

PMID:
19308428
17.

Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy.

Thapa P, Zhang G, Xia C, Gelbard A, Overwijk WW, Liu C, Hwu P, Chang DZ, Courtney A, Sastry JK, Wang PG, Li C, Zhou D.

Vaccine. 2009 May 26;27(25-26):3484-8. doi: 10.1016/j.vaccine.2009.01.047. Epub 2009 Feb 5.

PMID:
19200815
18.

Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.

Moorthy A, Gupta A, Bhosale R, Tripathy S, Sastry J, Kulkarni S, Thakar M, Bharadwaj R, Kagal A, Bhore AV, Patil S, Kulkarni V, Venkataramani V, Balasubramaniam U, Suryavanshi N, Ziemniak C, Gupte N, Bollinger R, Persaud D.

PLoS One. 2009;4(1):e4096. doi: 10.1371/journal.pone.0004096. Epub 2009 Jan 1.

19.

High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India.

Gupta A, Anand S, Sastry J, Krisagar A, Basavaraj A, Bhat SM, Gupte N, Bollinger RC, Kakrani AL.

BMC Infect Dis. 2008 Oct 21;8:142. doi: 10.1186/1471-2334-8-142.

20.

The Indian pediatric HIV epidemic: a systematic review.

Singh HK, Gupta A, Siberry GK, Gupte N, Sastry J, Kinikar A, Shah I, Gangakhedkar RR, Bollinger RC, Kulkarni V.

Curr HIV Res. 2008 Sep;6(5):419-32. Review.

PMID:
18855652

Supplemental Content

Loading ...
Support Center